EnantioBioIso Enantioselective strategies for the synthesis of phenyl bioisosteres
- Coordinator
- Universidad Autonoma De Madrid, Spain
- Runs
- 1 May 2024 to 30 April 2026
- Status
- Ended early
- EU funding
- €165k
- Total cost
- —
- Partners
- 2 organisations in 1 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101151954
What the project is doing
In the project's own words, from its summary on CORDIS.
The obtainment of enantioenriched molecules is of fundamental importance since two enantiomers of the same drug candidate can display completely different biological properties. In recent years, an increasing interest in employing saturated scaffolds has been observed in medicinal chemistry since they provide tridimensionality and well-defined exit vectors that give access to novel unexplored chemical space, leading to a higher success in drug discovery programs.
Among them, some polycyclic bridged skeletons have been identified as suitable saturated bioisosteres of aromatic rings which represent the common two-dimensional, flat moieties that are routinely employed in the drug discovery process. The aim of EnantioBioIso is to provide novel enantioselective strategies for the synthesis of phenyl bioisosteres, enabling unprecedented approaches to obtain bridged skeletons that are of fundamental importance for medicinal chemistry.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidad Autonoma De Madrid | Madrid | Spain | Coordinator |
| Fundacion Imdea Nanociencia | Madrid | Spain | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI